<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>L-Carnitine</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00583</strong>&#160; (APRD01070)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>Constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. [PubChem]</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00583/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00583/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00583.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00583.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00583.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00583.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00583.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00583">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="synonyms"><thead><th>Synonym</th><th>Language</th><th>Code</th></thead><tbody><tr><td>(-)-Carnitine</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>(-)-L-Carnitin</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>(S)-Carnitine</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Carnitine</td><td><span class="wishart wishart-not-available">Not Available</span></td><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><td>Levocarnitin</td><td>German</td><td>INN</td></tr><tr><td>Levocarnitina</td><td>Spanish</td><td>INN</td></tr><tr><td>L&#233;vocarnitine</td><td>French</td><td>INN</td></tr><tr><td>Levocarnitinum</td><td>Latin</td><td>INN</td></tr></tbody></table></td></tr><tr><th>Salts</th><td class="table-container"><table class="inner">
  <thead>
    <tr>
      <th>Name/CAS</th>
      <th>Structure</th>
      <th>Properties</th>
      <th></th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>
          <strong>L-Carnitin Hydrochloride</strong>
          <div class="cas"></div>
        </td>
        <td><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DBSALT001037/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DBSALT001037/thumb.png"></a></td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
        <td><a class="btn btn-default btn-xs" href="/salts/DBSALT001037">DBSALT001037</a></td>
      </tr>
  </tbody>
</table></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Albicar</td><td>Casasco</td></tr><tr><td>Aveptol</td><td>Leovan Pharmaceuticals</td></tr><tr><td>Biocarn</td><td>Medice</td></tr><tr><td>Bitobionil</td><td>S.J.A.</td></tr><tr><td>Cardimax</td><td>Integrated</td></tr><tr><td>Cardispan</td><td>Grossman</td></tr><tr><td>Carniben</td><td>Bennett Pharmaceuticals</td></tr><tr><td>Carnicor</td><td>Sigma Tau</td></tr><tr><td>Carnitor</td><td>Sigma-tau pharmacauticals </td></tr><tr><td>Lecarna</td><td>Bennett Pharmaceuticals</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="mixtures"><thead><tr><th>Brand Name</th><th>Ingredients</th></tr></thead><tbody><tr><td>Car-Q</td><td>Levocarnitine and Ubidecarenone</td></tr><tr><td>Carnon</td><td>Levocarnitine and Ubidecarenone</td></tr><tr><td>Evion-LC</td><td>Levocarnitine and Tocopherol, &#945;-</td></tr></tbody></table></td></tr><tr><th>Categories</th><td><ul><li><a href="/mesh/vitamin-b-complex">Vitamin B Complex</a></li>
<li><a href="/mesh/dietary-supplements">Dietary Supplements</a></li></ul></td></tr><tr><th>CAS number</th><td>541-15-1</td></tr><tr><th>Weight</th><td>Average: 161.1989<br>Monoisotopic: 161.105193351</td></tr><tr><th>Chemical Formula</th><td>C<sub>7</sub>H<sub>15</sub>NO<sub>3</sub></td></tr><tr><th>InChI Key</th><td>PHIQHXFUZVPYII-ZCFIWIBFSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m1/s1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">(3R)-3-hydroxy-4-(trimethylazaniumyl)butanoate</div></td></tr><tr><th>SMILES</th><td><div class="wrap">C[N+](C)(C)C[C@H](O)CC([O-])=O</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Organonitrogen Compounds</td></tr><tr><th>Class</th><td>Quaternary Ammonium Salts</td></tr><tr><th>Subclass</th><td>Carnitines</td></tr><tr><th>Direct parent</th><td>Carnitines</td></tr><tr><th>Alternative parents</th><td>Beta Hydroxy Acids and Derivatives; Cholines; Secondary Alcohols; Polyamines; Carboxylic Acid Salts; Enolates</td></tr><tr><th>Substituents</th><td>beta-hydroxy acid; choline; hydroxy acid; secondary alcohol; polyamine; enolate; carboxylic acid derivative; carboxylic acid salt; alcohol; amine</td></tr><tr><th>Classification description</th><td>This compound belongs to the carnitines. These are organic compounds containing the quaternary ammonium compound carnitine.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For treatment of primary systemic carnitine deficiency, a genetic impairment of normal biosynthesis or utilization of levocarnitine from dietary sources, or for the treatment of secondary carnitine deficiency resulting from an inborn error of metabolism such as glutaric aciduria II, methyl malonic aciduria, propionic acidemia, and medium chain fatty acylCoA dehydrogenase deficiency. Used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias. Parenteral levocarnitine is indicated for the prevention and treatment of carnitine deficiency in patients with end-stage renal disease.</td></tr><tr><th>Pharmacodynamics</th><td>Levocarnitine is a carrier molecule in the transport of long chain fatty acids across the inner mitochondrial membrane. It also exports acyl groups from subcellular organelles and from cells to urine before they accumulate to toxic concentrations. Lack of carnitine can lead to liver, heart, and muscle problems. Carnitine deficiency is defined biochemically as abnormally low plasma concentrations of free carnitine, less than 20 &#181;mol/L at one week post term and may be associated with low tissue and/or urine concentrations. Further, this condition may be associated with a plasma concentration ratio of acylcarnitine/levocarnitine greater than 0.4 or abnormally elevated concentrations of acylcarnitine in the urine. Only the L isomer of carnitine (sometimes called vitamin BT) affects lipid metabolism. The "vitamin BT" form actually contains D,L-carnitine, which competitively inhibits levocarnitine and can cause deficiency. Levocarnitine can be used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.</td></tr><tr><th>Mechanism of action</th><td>Levocarnitine can be synthesised within the body from the amino acids lysine or methionine. Vitamin C (ascorbic acid) is essential to the synthesis of carnitine. Levocarnitine is a carrier molecule in the transport of long chain fatty acids across the inner mitochondrial membrane. It also exports acyl groups from subcellular organelles and from cells to urine before they accumulate to toxic concentrations. Only the L isomer of carnitine (sometimes called vitamin BT) affects lipid metabolism. Levocarnitine is handled by several proteins in different pathways including carnitine transporters, carnitine translocases, carnitine acetyltransferases and carnitine palmitoyltransferases.</td></tr><tr><th>Absorption</th><td>Absolute bioavailability is 15% (tablets or solution).
Time to maximum plasma concentration was found to be 3.3 hours. </td></tr><tr><th>Volume of distribution</th><td><p>The steady state volume of distribution (Vss) of an intravenously administered dose, above endogenous baseline levels, was calculated to be 29.0 +/- 7.1L. However this value is predicted to be an underestimate of the true Vss.</p></td></tr><tr><th>Protein binding</th><td>None</td></tr><tr><th>Metabolism</th><td class="data-table-container"><p>After oral administration L-carnitine which is unabsorbed is metabolized in the gastrointestinal tract by bacterial microflora. Major metabolites include trimethylamine N-oxide and [3H]-gamma-butyrobetaine.</p><table class="table-standard table-condensed" id="experimental-properties"><thead><tr><th>Substrate</th><th>Enzymes</th><th colspan="2">Product</th></tr></thead><tbody><tr><td>L-Carnitine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00513">Trimethylamine N-oxide</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/527">Details</a></td></tr><tr><td>L-Carnitine</td><td class="enzymes"><div class="arrow"><span class="glyphicon glyphicon-arrow-right"> </span></div><span class="wishart wishart-not-available">Not Available</span></td><td><a href="/metabolites/DBMET00521">[3H]-gamma-Butyrobetaine</a></td><td class="actions"><a class="btn btn-info btn-sm" href="/reactions/536">Details</a></td></tr></tbody></table></td></tr><tr><th>Route of elimination</th><td>Following a single intravenous dose, 73.1 +/- 16% of the dose was excreted in the urine during the 0-24 hour interval. 
Post administration of oral carnitine supplements, in addition to a high carnitine diet, 58-65% of the administered radioactive dose was recovered from urine and feces in 5-11 days. 
</td></tr><tr><th>Half life</th><td>17.4 hours (elimination) following a single intravenous dose.
</td></tr><tr><th>Clearance</th><td><p>Total body clearance was found to be a mean of 4L/h.</p></td></tr><tr><th>Toxicity</th><td>LD<sub>50</sub> &gt; 8g/kg (mouse, oral). Adverse effects include hypertension, fever, tachycardia and seizures.</td></tr><tr><th>Affected organisms</th><td><ul><li>Humans and other mammals</li></ul></td></tr><tr><th>Pathways</th><td class="data-table-container"><table class="table table-condensed table-striped" id="pathways"><thead><tr><th>Pathway</th><th>Category</th></tr></thead><tbody><tr><td>Fatty acid Metabolism</td><td>Metabolic</td></tr><tr><td>Oxidation of Branched Chain Fatty Acids</td><td>Metabolic</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00030?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00030</a></td></tr><tr><td>Beta Oxidation of Very Long Chain Fatty Acids</td><td>Metabolic</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00052?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00052</a></td></tr><tr><td>Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids</td><td>Metabolic</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00482?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00482</a></td></tr><tr><td>Glutaric Aciduria Type I</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00185?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00185</a></td></tr><tr><td>Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00235?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00235</a></td></tr><tr><td>Medium chain acyl-coa dehydrogenase deficiency (MCAD)</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00542?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00542</a></td></tr><tr><td>Long chain acyl-CoA dehydrogenase deficiency (LCAD)</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00539?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00539</a></td></tr><tr><td>Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00540?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00540</a></td></tr><tr><td>Carnitine-acylcarnitine translocase deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00517?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00517</a></td></tr><tr><td>Adrenoleukodystrophy, X-linked</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00516?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00516</a></td></tr><tr><td>Carnitine Synthesis</td><td>Metabolic</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00465?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00465</a></td></tr><tr><td>Carnitine palmitoyl transferase deficiency (II)</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00541?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00541</a></td></tr><tr><td>Carnitine palmitoyl transferase deficiency (I)</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00538?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00538</a></td></tr><tr><td>Trifunctional protein deficiency</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00545?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00545</a></td></tr><tr><td>Ethylmalonic Encephalopathy</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00181?highlight%5Bcompounds%5D%5B%5D=DB00583&amp;highlight%5Bproteins%5D%5B%5D=DB00583">SMP00181</a></td></tr></tbody></table></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              -
        </td>
        <td>0.9409</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              +
        </td>
        <td>0.8568</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              +
        </td>
        <td>0.5952</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.6583</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9784</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.8966</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9161</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8372</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.845</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.5297</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9361</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.951</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9382</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9348</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9627</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9874</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.8832
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Carcinogens  
        </td>
        <td>
            0.6127
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Ready biodegradable 
        </td>
        <td>
            0.9234
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.1624 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9731
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.914
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>Sigma tau pharmaceuticals inc</li>
<li>Bedford laboratories div ben venue laboratories inc</li>
<li>Luitpold pharmaceuticals inc</li>
<li>Teva parenteral medicines inc</li>
<li>Hi tech pharmacal co inc</li>
<li>Lyne laboratories inc</li>
<li>Corepharma llc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.mclarenmedical.com">McLaren Medical</a></li>
<li><a href="http://www.sigmatau.com">Sigma-Tau Pharmaceuticals Inc.</a></li>
<li><a href="http://www.spectrumpharm.com">Spectrum Pharmaceuticals</a></li>
<li>Vitaline Corp.</li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Injection</td><td>Intravenous</td><td>200mg/mL</td></tr><tr><td>Liquid</td><td>Oral</td><td></td></tr><tr><td>Solution</td><td>Intravenous</td><td></td></tr><tr><td>Solution</td><td>Oral</td><td>1g/10mL</td></tr><tr><td>Tablet</td><td>Oral</td><td></td></tr><tr><td>Tablet</td><td>Oral</td><td>330mg</td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td>Searched, but no interactions found.</td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>